Cargando…
Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization
SIMPLE SUMMARY: Angiogenesis, the sprouting of new capillaries from existing vessels, plays a crucial role in various physiological processes. Pathological vascularization, as seen in, e.g., cancer, musculoskeletal diseases, or ocular disorders, eventually causes tissue and organ dysfunctions. Vascu...
Autores principales: | Lessiak, Ulrike, Pratscher, Barbara, Tichy, Alexander, Nell, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675369/ https://www.ncbi.nlm.nih.gov/pubmed/37999456 http://dx.doi.org/10.3390/vetsci10110632 |
Ejemplares similares
-
Serum vascular endothelial growth factor changes and safety after topical anti‐human VEGF antibody bevacizumab in healthy dogs
por: Muellerleile, Lisa‐Marie, et al.
Publicado: (2019) -
Immunohistochemical staining of immunoglobulin G in healthy equine, canine, and feline corneas
por: Herb, Verena Maria, et al.
Publicado: (2022) -
Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling
por: Zhang, Xiaoling, et al.
Publicado: (2020) -
Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells
por: Izuta, Hiroshi, et al.
Publicado: (2009) -
Betulinic acid shows anticancer activity against equine melanoma cells and permeates isolated equine skin in vitro
por: Weber, Lisa A., et al.
Publicado: (2020)